Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees†.
Annals of oncology : official journal of the European Society for Medical Oncology·2019
ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology·2018
The ESMO guideline strategy: an identity statement and reflections on improvement.
Annals of oncology : official journal of the European Society for Medical Oncology·2015
Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2014
Second cancer risk and mortality in men treated with radiotherapy for stage I seminoma.
British journal of cancer·2013
Survival benefit of recurrence-focused treatment after surgery for pancreatic ductal adenocarcinoma: A propensity score matched analysis of patients from a Dutch National and US institutional cohort.
European journal of cancer (Oxford, England : 1990)·2026
Perioperative chemotherapy and long-term cure in resected grade 3 gastroenteropancreatic neuroendocrine carcinomas: The GETNE SOUTH-NEC Study.
European journal of cancer (Oxford, England : 1990)·2026
Pain in epithelioid hemangioendothelioma: Development of disease-specific pain assessment criteria (PAC-E).
European journal of cancer (Oxford, England : 1990)·2026
Frozen section analysis assisted MRI targeted prostate biopsy - results of the randomized clinical FAST trial.
European journal of cancer (Oxford, England : 1990)·2026
Real-life efficacy and tolerance of trametinib in BRAF-rearranged low-grade gliomas: A multicenter study.
European journal of cancer (Oxford, England : 1990)·2026
Exploration of tumor genomics associated with prolonged benefit from or resistance to talazoparib monotherapy in patients with metastatic castration-resistant prostate cancer.
European journal of cancer (Oxford, England : 1990)·2026